Rank | Gene Set | Z-score |
---|---|---|
1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 8.61585668 |
2 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 8.04342885 |
3 | ATP synthesis coupled proton transport (GO:0015986) | 8.04342885 |
4 | * mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 7.74255441 |
5 | * respiratory electron transport chain (GO:0022904) | 7.26197463 |
6 | * electron transport chain (GO:0022900) | 7.07684163 |
7 | oxidative phosphorylation (GO:0006119) | 5.89622543 |
8 | tricarboxylic acid cycle (GO:0006099) | 5.65284734 |
9 | regulation of somitogenesis (GO:0014807) | 5.39320402 |
10 | * protein complex biogenesis (GO:0070271) | 5.15258596 |
11 | NADH metabolic process (GO:0006734) | 5.07051112 |
12 | * mitochondrial respiratory chain complex I assembly (GO:0032981) | 5.03765372 |
13 | * NADH dehydrogenase complex assembly (GO:0010257) | 5.03765372 |
14 | * mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 5.03765372 |
15 | * mitochondrial respiratory chain complex assembly (GO:0033108) | 4.90817731 |
16 | regulation of mitochondrial translation (GO:0070129) | 4.83220311 |
17 | ubiquinone biosynthetic process (GO:0006744) | 4.76497008 |
18 | quinone biosynthetic process (GO:1901663) | 4.76497008 |
19 | ATP biosynthetic process (GO:0006754) | 4.72118533 |
20 | inner mitochondrial membrane organization (GO:0007007) | 4.46911830 |
21 | sarcomere organization (GO:0045214) | 4.37801338 |
22 | heart contraction (GO:0060047) | 4.31881770 |
23 | heart process (GO:0003015) | 4.31881770 |
24 | respiratory chain complex IV assembly (GO:0008535) | 4.30768099 |
25 | DNA deamination (GO:0045006) | 4.24485863 |
26 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.23605915 |
27 | hydrogen ion transmembrane transport (GO:1902600) | 4.23244475 |
28 | ubiquinone metabolic process (GO:0006743) | 4.18379463 |
29 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 4.16393536 |
30 | chaperone-mediated protein transport (GO:0072321) | 4.15920765 |
31 | sulfation (GO:0051923) | 4.13133680 |
32 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 4.12611973 |
33 | aerobic respiration (GO:0009060) | 4.08656058 |
34 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.98724583 |
35 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.97711775 |
36 | cytochrome complex assembly (GO:0017004) | 3.96383380 |
37 | GDP-mannose metabolic process (GO:0019673) | 3.94851901 |
38 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.92226751 |
39 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.91033962 |
40 | actin-myosin filament sliding (GO:0033275) | 3.85017569 |
41 | muscle filament sliding (GO:0030049) | 3.85017569 |
42 | succinate metabolic process (GO:0006105) | 3.78753959 |
43 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.73170251 |
44 | proton transport (GO:0015992) | 3.71316044 |
45 | viral mRNA export from host cell nucleus (GO:0046784) | 3.70145925 |
46 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.69451269 |
47 | hydrogen transport (GO:0006818) | 3.64822200 |
48 | regulation of relaxation of muscle (GO:1901077) | 3.62707880 |
49 | regulation of cofactor metabolic process (GO:0051193) | 3.58366011 |
50 | regulation of coenzyme metabolic process (GO:0051196) | 3.58366011 |
51 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.57386342 |
52 | oxaloacetate metabolic process (GO:0006107) | 3.56018017 |
53 | pseudouridine synthesis (GO:0001522) | 3.55145583 |
54 | myofibril assembly (GO:0030239) | 3.54584315 |
55 | regulation of skeletal muscle contraction (GO:0014819) | 3.53909113 |
56 | cardiac myofibril assembly (GO:0055003) | 3.52980240 |
57 | proteasome assembly (GO:0043248) | 3.48877057 |
58 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.45562454 |
59 | DNA integration (GO:0015074) | 3.44009672 |
60 | mitochondrial transport (GO:0006839) | 3.42669244 |
61 | positive regulation of prostaglandin secretion (GO:0032308) | 3.40367902 |
62 | regulation of oxidative phosphorylation (GO:0002082) | 3.39713547 |
63 | heparin biosynthetic process (GO:0030210) | 3.33152724 |
64 | heparin metabolic process (GO:0030202) | 3.33152724 |
65 | cellular respiration (GO:0045333) | 3.32597600 |
66 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.32410301 |
67 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.32410301 |
68 | metallo-sulfur cluster assembly (GO:0031163) | 3.30106032 |
69 | iron-sulfur cluster assembly (GO:0016226) | 3.30106032 |
70 | L-methionine salvage (GO:0071267) | 3.29441976 |
71 | L-methionine biosynthetic process (GO:0071265) | 3.29441976 |
72 | amino acid salvage (GO:0043102) | 3.29441976 |
73 | regulation of cellular respiration (GO:0043457) | 3.29409835 |
74 | cardiac muscle contraction (GO:0060048) | 3.28911806 |
75 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.27275946 |
76 | protein targeting to mitochondrion (GO:0006626) | 3.27082931 |
77 | nucleoside triphosphate biosynthetic process (GO:0009142) | 3.26068380 |
78 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.23794860 |
79 | establishment of protein localization to mitochondrion (GO:0072655) | 3.21381321 |
80 | peptidyl-histidine modification (GO:0018202) | 3.17101977 |
81 | branched-chain amino acid catabolic process (GO:0009083) | 3.15010236 |
82 | creatine metabolic process (GO:0006600) | 3.10821143 |
83 | negative regulation of B cell apoptotic process (GO:0002903) | 3.09021290 |
84 | heme biosynthetic process (GO:0006783) | 3.07870264 |
85 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.07441033 |
86 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.04955814 |
87 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.04955814 |
88 | regulation of cell communication by electrical coupling (GO:0010649) | 3.03705091 |
89 | cytidine metabolic process (GO:0046087) | 3.00962329 |
90 | cytidine catabolic process (GO:0006216) | 3.00962329 |
91 | cytidine deamination (GO:0009972) | 3.00962329 |
92 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.00287509 |
93 | rRNA modification (GO:0000154) | 3.00273990 |
94 | base-excision repair, AP site formation (GO:0006285) | 2.98947341 |
95 | actin-mediated cell contraction (GO:0070252) | 2.97950099 |
96 | protein localization to mitochondrion (GO:0070585) | 2.96929005 |
97 | * generation of precursor metabolites and energy (GO:0006091) | 2.95402122 |
98 | quinone metabolic process (GO:1901661) | 2.95132216 |
99 | regulation of actin filament-based movement (GO:1903115) | 2.95079789 |
100 | replicative senescence (GO:0090399) | 2.92918540 |
101 | ribosomal small subunit assembly (GO:0000028) | 2.91242643 |
102 | positive regulation of action potential (GO:0045760) | 2.90118623 |
103 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.88246894 |
104 | termination of RNA polymerase III transcription (GO:0006386) | 2.88246894 |
105 | positive regulation of mitochondrial fission (GO:0090141) | 2.87127881 |
106 | mitochondrial membrane organization (GO:0007006) | 2.83477851 |
107 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.82912443 |
108 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.82329909 |
109 | mitochondrion morphogenesis (GO:0070584) | 2.81697582 |
110 | purine ribonucleoside biosynthetic process (GO:0046129) | 2.81337288 |
111 | purine nucleoside biosynthetic process (GO:0042451) | 2.81337288 |
112 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.80978145 |
113 | protein neddylation (GO:0045116) | 2.80518267 |
114 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.75734517 |
115 | ribonucleoside monophosphate biosynthetic process (GO:0009156) | 2.75720703 |
116 | aspartate family amino acid catabolic process (GO:0009068) | 2.75118906 |
117 | fatty acid beta-oxidation (GO:0006635) | 2.74021167 |
118 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.73419362 |
119 | regulation of striated muscle contraction (GO:0006942) | 2.71565008 |
120 | regulation of sulfur metabolic process (GO:0042762) | 2.70805567 |
121 | skeletal muscle contraction (GO:0003009) | 2.70540726 |
122 | striated muscle contraction (GO:0006941) | 2.70034230 |
123 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.69778843 |
124 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.69410857 |
125 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.69410857 |
126 | regulation of action potential (GO:0098900) | 2.69114716 |
127 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.68128410 |
128 | nucleotide salvage (GO:0043173) | 2.63214005 |
129 | mannosylation (GO:0097502) | 2.62765310 |
130 | skeletal muscle fiber development (GO:0048741) | 2.62654962 |
131 | cardiac muscle hypertrophy (GO:0003300) | 2.62069576 |
132 | GTP biosynthetic process (GO:0006183) | 2.58432326 |
133 | cellular potassium ion homeostasis (GO:0030007) | 2.57525410 |
134 | muscle hypertrophy (GO:0014896) | 2.56401851 |
135 | tRNA modification (GO:0006400) | 2.54314926 |
136 | intracellular protein transmembrane import (GO:0044743) | 2.54038135 |
137 | positive regulation of TOR signaling (GO:0032008) | 2.53984872 |
138 | regulation of membrane repolarization (GO:0060306) | 2.52619933 |
139 | purine nucleotide salvage (GO:0032261) | 2.50423813 |
140 | myotube cell development (GO:0014904) | 2.49655364 |
141 | striated muscle hypertrophy (GO:0014897) | 2.49154971 |
142 | peroxisome fission (GO:0016559) | 2.48011203 |
143 | response to misfolded protein (GO:0051788) | 2.47023454 |
144 | rRNA methylation (GO:0031167) | 2.46881253 |
145 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.45600490 |
146 | negative regulation of telomere maintenance (GO:0032205) | 2.43642242 |
Rank | Gene Set | Z-score |
---|---|---|
1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.44206838 |
2 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.92456335 |
3 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.76789761 |
4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.74652806 |
5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.54517372 |
6 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 3.50024888 |
7 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.47307854 |
8 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.27162804 |
9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.25418673 |
10 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.21757022 |
11 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.20523302 |
12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.11127382 |
13 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 3.10564880 |
14 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.08338282 |
15 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.03379550 |
16 | * HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.94722772 |
17 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.84016872 |
18 | * YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.83159511 |
19 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.69487822 |
20 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.65732578 |
21 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.58823839 |
22 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.51700675 |
23 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.44499739 |
24 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.34096514 |
25 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.32039991 |
26 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.29209479 |
27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.28794492 |
28 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.23210227 |
29 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.18239667 |
30 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.12805591 |
31 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.12761197 |
32 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.04155172 |
33 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99560576 |
34 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.96390781 |
35 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.90266432 |
36 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.90138940 |
37 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.87155250 |
38 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.86200136 |
39 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84924384 |
40 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.76018666 |
41 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.70930664 |
42 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.67175150 |
43 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.66429388 |
44 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.64794960 |
45 | * P68_20966046_ChIP-Seq_HELA_Human | 1.61770774 |
46 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.56607513 |
47 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.54139278 |
48 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.53142287 |
49 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.49303476 |
50 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.48435757 |
51 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.46748341 |
52 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.42468262 |
53 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.42207691 |
54 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.40711738 |
55 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36312819 |
56 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.35818141 |
57 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.35405242 |
58 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.35162120 |
59 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31045636 |
60 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.30897887 |
61 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.30712519 |
62 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.30411622 |
63 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.30307033 |
64 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.29817900 |
65 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29188307 |
66 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.28795673 |
67 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.27906231 |
68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.26783903 |
69 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.23730638 |
70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.22116801 |
71 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.21889722 |
72 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.20719864 |
73 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.15349431 |
74 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.15158128 |
75 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.15118154 |
76 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.14812406 |
77 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.14744934 |
78 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.14529641 |
79 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.14039705 |
80 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.13619977 |
81 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12095301 |
82 | SA1_27219007_Chip-Seq_Bcells_Human | 1.11947687 |
83 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.11489877 |
84 | MAF_26560356_Chip-Seq_TH2_Human | 1.11353185 |
85 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.10875583 |
86 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.09661104 |
87 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.09185325 |
88 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08661340 |
89 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08035385 |
90 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.07831557 |
91 | * P300_27268052_Chip-Seq_Bcells_Human | 1.07268674 |
92 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.07156526 |
93 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.07065593 |
94 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.06394791 |
95 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.06351580 |
96 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.06288458 |
97 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.06190276 |
98 | ERA_21632823_ChIP-Seq_H3396_Human | 1.05512049 |
99 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.04521178 |
100 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.03952356 |
101 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.03240795 |
102 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.02666192 |
103 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.01086097 |
104 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.01054400 |
105 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00047546 |
106 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.99795417 |
107 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.99761931 |
108 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.98973229 |
109 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.98581918 |
110 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98490275 |
111 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.97078528 |
112 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.96945886 |
113 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.95855987 |
114 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.95528660 |
115 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.94398137 |
116 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.92257245 |
117 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.92233157 |
118 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91886436 |
119 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91456406 |
120 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.90331494 |
121 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.89907810 |
122 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.89519781 |
123 | * KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.89462944 |
124 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.88758804 |
125 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.88652967 |
126 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.88515983 |
127 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.88383814 |
128 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.87137910 |
129 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.85781023 |
130 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.83252539 |
131 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.82235580 |
132 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.81682760 |
133 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.81547382 |
134 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.80974855 |
135 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.80818652 |
136 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.79591279 |
137 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.78267031 |
138 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.77875031 |
139 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.77418860 |
140 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.76946949 |
141 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.76335603 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003646_muscle_fatigue | 5.80340342 |
2 | MP0002837_dystrophic_cardiac_calcinosis | 5.58960541 |
3 | MP0000751_myopathy | 4.29853154 |
4 | MP0000749_muscle_degeneration | 3.89431255 |
5 | MP0004084_abnormal_cardiac_muscle | 3.81350001 |
6 | MP0004215_abnormal_myocardial_fiber | 3.68516931 |
7 | MP0006036_abnormal_mitochondrial_physio | 3.59429087 |
8 | MP0004036_abnormal_muscle_relaxation | 3.46863491 |
9 | MP0003806_abnormal_nucleotide_metabolis | 3.19294587 |
10 | MP0005330_cardiomyopathy | 3.04603863 |
11 | MP0004147_increased_porphyrin_level | 2.68570760 |
12 | MP0006035_abnormal_mitochondrial_morpho | 2.51500902 |
13 | MP0002138_abnormal_hepatobiliary_system | 2.42959528 |
14 | MP0003137_abnormal_impulse_conducting | 2.38516496 |
15 | MP0002972_abnormal_cardiac_muscle | 2.22056337 |
16 | MP0004484_altered_response_of | 2.06940278 |
17 | MP0005360_urolithiasis | 2.06815036 |
18 | MP0004145_abnormal_muscle_electrophysio | 2.02318012 |
19 | MP0002106_abnormal_muscle_physiology | 2.01453414 |
20 | MP0000750_abnormal_muscle_regeneration | 1.98575487 |
21 | MP0009379_abnormal_foot_pigmentation | 1.96592731 |
22 | MP0005620_abnormal_muscle_contractility | 1.94952766 |
23 | MP0008775_abnormal_heart_ventricle | 1.94547116 |
24 | MP0005171_absent_coat_pigmentation | 1.93331660 |
25 | MP0001529_abnormal_vocalization | 1.90769513 |
26 | MP0004087_abnormal_muscle_fiber | 1.84626527 |
27 | MP0002269_muscular_atrophy | 1.83249919 |
28 | MP0005423_abnormal_somatic_nervous | 1.79266602 |
29 | MP0000747_muscle_weakness | 1.77455478 |
30 | MP0005385_cardiovascular_system_phenoty | 1.71420351 |
31 | MP0001544_abnormal_cardiovascular_syste | 1.71420351 |
32 | MP0005670_abnormal_white_adipose | 1.65855192 |
33 | MP0002160_abnormal_reproductive_system | 1.64548203 |
34 | MP0002163_abnormal_gland_morphology | 1.60788405 |
35 | MP0009046_muscle_twitch | 1.58808988 |
36 | MP0005369_muscle_phenotype | 1.58360910 |
37 | MP0004130_abnormal_muscle_cell | 1.57034613 |
38 | MP0004043_abnormal_pH_regulation | 1.51496974 |
39 | MP0003186_abnormal_redox_activity | 1.50757867 |
40 | MP0009840_abnormal_foam_cell | 1.49939089 |
41 | MP0001502_abnormal_circadian_rhythm | 1.49744329 |
42 | MP0006138_congestive_heart_failure | 1.46142405 |
43 | MP0004085_abnormal_heartbeat | 1.44227190 |
44 | MP0003221_abnormal_cardiomyocyte_apopto | 1.42944774 |
45 | MP0004142_abnormal_muscle_tone | 1.40593455 |
46 | MP0002332_abnormal_exercise_endurance | 1.40309034 |
47 | MP0003656_abnormal_erythrocyte_physiolo | 1.40190593 |
48 | MP0000759_abnormal_skeletal_muscle | 1.39770768 |
49 | MP0000678_abnormal_parathyroid_gland | 1.36855703 |
50 | MP0002735_abnormal_chemical_nociception | 1.35550428 |
51 | MP0005083_abnormal_biliary_tract | 1.31889087 |
52 | MP0009697_abnormal_copulation | 1.30081857 |
53 | MP0002139_abnormal_hepatobiliary_system | 1.29857605 |
54 | MP0005266_abnormal_metabolism | 1.28722115 |
55 | MP0003828_pulmonary_edema | 1.26981498 |
56 | MP0004859_abnormal_synaptic_plasticity | 1.26743331 |
57 | MP0001905_abnormal_dopamine_level | 1.26192503 |
58 | MP0004510_myositis | 1.24206143 |
59 | MP0010630_abnormal_cardiac_muscle | 1.22816971 |
60 | MP0003880_abnormal_central_pattern | 1.21283082 |
61 | MP0005058_abnormal_lysosome_morphology | 1.16316044 |
62 | MP0005332_abnormal_amino_acid | 1.14862150 |
63 | MP0005646_abnormal_pituitary_gland | 1.12451800 |
64 | MP0004270_analgesia | 1.12369168 |
65 | MP0003693_abnormal_embryo_hatching | 1.10385234 |
66 | MP0001970_abnormal_pain_threshold | 1.06005101 |
67 | MP0002272_abnormal_nervous_system | 1.05923548 |
68 | MP0005389_reproductive_system_phenotype | 1.05233386 |
69 | MP0009764_decreased_sensitivity_to | 1.04521484 |
70 | MP0000230_abnormal_systemic_arterial | 1.03461509 |
71 | MP0003635_abnormal_synaptic_transmissio | 1.00675891 |
72 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.99915122 |
73 | MP0006072_abnormal_retinal_apoptosis | 0.99089893 |
74 | MP0005165_increased_susceptibility_to | 0.94737274 |
75 | MP0003950_abnormal_plasma_membrane | 0.94411351 |
76 | MP0003195_calcinosis | 0.94398734 |
77 | MP0001764_abnormal_homeostasis | 0.94373762 |
78 | MP0002822_catalepsy | 0.94355981 |
79 | MP0002733_abnormal_thermal_nociception | 0.94102695 |
80 | MP0008569_lethality_at_weaning | 0.93914473 |
81 | MP0005410_abnormal_fertilization | 0.89435750 |
82 | MP0002127_abnormal_cardiovascular_syste | 0.88044789 |
83 | MP0004233_abnormal_muscle_weight | 0.86398623 |
84 | MP0005319_abnormal_enzyme/_coenzyme | 0.85555177 |
85 | MP0005671_abnormal_response_to | 0.85523593 |
86 | MP0008260_abnormal_autophagy | 0.85346205 |
87 | MP0002736_abnormal_nociception_after | 0.84491854 |
88 | MP0000049_abnormal_middle_ear | 0.84045113 |
89 | MP0005636_abnormal_mineral_homeostasis | 0.82981183 |
90 | MP0003879_abnormal_hair_cell | 0.81311264 |
91 | MP0005379_endocrine/exocrine_gland_phen | 0.80878802 |
92 | MP0005085_abnormal_gallbladder_physiolo | 0.79431112 |
93 | MP0005551_abnormal_eye_electrophysiolog | 0.76910324 |
94 | MP0002064_seizures | 0.76900037 |
95 | MP0001440_abnormal_grooming_behavior | 0.76403162 |
96 | MP0002653_abnormal_ependyma_morphology | 0.76088514 |
97 | MP0000343_altered_response_to | 0.75522354 |
98 | MP0002063_abnormal_learning/memory/cond | 0.74781822 |
99 | MP0005253_abnormal_eye_physiology | 0.73645442 |
100 | MP0001485_abnormal_pinna_reflex | 0.73583353 |
101 | MP0005535_abnormal_body_temperature | 0.73199292 |
102 | MP0005084_abnormal_gallbladder_morpholo | 0.72593188 |
103 | MP0002734_abnormal_mechanical_nocicepti | 0.72453060 |
104 | MP0002572_abnormal_emotion/affect_behav | 0.72235336 |
105 | MP0001486_abnormal_startle_reflex | 0.71885241 |
106 | MP0009643_abnormal_urine_homeostasis | 0.71533784 |
107 | MP0000003_abnormal_adipose_tissue | 0.71432722 |
108 | MP0000358_abnormal_cell_content/ | 0.70649145 |
109 | MP0008875_abnormal_xenobiotic_pharmacok | 0.70134171 |
110 | MP0005645_abnormal_hypothalamus_physiol | 0.69636882 |
111 | MP0003011_delayed_dark_adaptation | 0.69602999 |
112 | MP0005376_homeostasis/metabolism_phenot | 0.68754426 |
113 | MP0003567_abnormal_fetal_cardiomyocyte | 0.68489799 |
114 | MP0000920_abnormal_myelination | 0.68095969 |
115 | MP0000685_abnormal_immune_system | 0.67901942 |
116 | MP0004742_abnormal_vestibular_system | 0.66663538 |
117 | MP0001756_abnormal_urination | 0.66134325 |
118 | MP0002638_abnormal_pupillary_reflex | 0.64558894 |
119 | MP0006276_abnormal_autonomic_nervous | 0.63879330 |
120 | MP0005386_behavior/neurological_phenoty | 0.63141172 |
121 | MP0004924_abnormal_behavior | 0.63141172 |
122 | MP0002078_abnormal_glucose_homeostasis | 0.62087285 |
123 | MP0008872_abnormal_physiological_respon | 0.60541711 |
124 | MP0001663_abnormal_digestive_system | 0.58300446 |
125 | MP0005451_abnormal_body_composition | 0.58213904 |
126 | MP0002118_abnormal_lipid_homeostasis | 0.56826356 |
127 | MP0005365_abnormal_bile_salt | 0.56388894 |
128 | MP0003191_abnormal_cellular_cholesterol | 0.55939616 |
129 | MP0000013_abnormal_adipose_tissue | 0.55464212 |
130 | MP0002876_abnormal_thyroid_physiology | 0.55303081 |
131 | MP0001986_abnormal_taste_sensitivity | 0.54978302 |
132 | MP0000372_irregular_coat_pigmentation | 0.54906965 |
133 | MP0005375_adipose_tissue_phenotype | 0.54644882 |
134 | MP0001968_abnormal_touch/_nociception | 0.54418674 |
135 | MP0009745_abnormal_behavioral_response | 0.53154199 |
136 | MP0001664_abnormal_digestion | 0.52246922 |
137 | MP0002229_neurodegeneration | 0.49810829 |
138 | MP0002067_abnormal_sensory_capabilities | 0.48282343 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Acute necrotizing encephalopathy (HP:0006965) | 6.60220775 |
2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 6.31051457 |
3 | * Mitochondrial inheritance (HP:0001427) | 5.90953069 |
4 | * Hepatocellular necrosis (HP:0001404) | 5.85420420 |
5 | Acute encephalopathy (HP:0006846) | 5.69532226 |
6 | * Hepatic necrosis (HP:0002605) | 5.61431393 |
7 | Progressive macrocephaly (HP:0004481) | 5.35983650 |
8 | * Increased CSF lactate (HP:0002490) | 5.27309185 |
9 | Oral leukoplakia (HP:0002745) | 4.68147895 |
10 | Cerebral edema (HP:0002181) | 4.39829019 |
11 | * Lactic acidosis (HP:0003128) | 4.28146700 |
12 | Lipid accumulation in hepatocytes (HP:0006561) | 4.14979409 |
13 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 4.14417859 |
14 | Exercise intolerance (HP:0003546) | 4.06046008 |
15 | Increased intramyocellular lipid droplets (HP:0012240) | 4.02600907 |
16 | Increased hepatocellular lipid droplets (HP:0006565) | 4.02368903 |
17 | Increased muscle lipid content (HP:0009058) | 4.01178377 |
18 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.97897551 |
19 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.97897551 |
20 | * Respiratory failure (HP:0002878) | 3.97651179 |
21 | Sudden death (HP:0001699) | 3.96265077 |
22 | Anomalous pulmonary venous return (HP:0010772) | 3.88627757 |
23 | * Increased serum lactate (HP:0002151) | 3.78152335 |
24 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.67630129 |
25 | Muscle fiber inclusion bodies (HP:0100299) | 3.58657486 |
26 | Calf muscle hypertrophy (HP:0008981) | 3.57367448 |
27 | Abnormality of glycolysis (HP:0004366) | 3.55239817 |
28 | Increased serum pyruvate (HP:0003542) | 3.55239817 |
29 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.47931539 |
30 | Exercise-induced muscle cramps (HP:0003710) | 3.42953163 |
31 | Myoglobinuria (HP:0002913) | 3.40708993 |
32 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.40514528 |
33 | Renal Fanconi syndrome (HP:0001994) | 3.38753617 |
34 | Abnormality of the pulmonary veins (HP:0011718) | 3.36427433 |
35 | Exercise-induced myalgia (HP:0003738) | 3.34562143 |
36 | Optic disc pallor (HP:0000543) | 3.32758835 |
37 | Nemaline bodies (HP:0003798) | 3.30526252 |
38 | Palpitations (HP:0001962) | 3.30203117 |
39 | Leukodystrophy (HP:0002415) | 3.13721582 |
40 | Ventricular tachycardia (HP:0004756) | 3.13085839 |
41 | Myopathic facies (HP:0002058) | 3.08656093 |
42 | Rhabdomyolysis (HP:0003201) | 3.04409235 |
43 | 3-Methylglutaconic aciduria (HP:0003535) | 3.03041911 |
44 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.02218354 |
45 | Dicarboxylic aciduria (HP:0003215) | 3.02218354 |
46 | Rough bone trabeculation (HP:0100670) | 2.86848880 |
47 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.84820550 |
48 | Atrial fibrillation (HP:0005110) | 2.84309625 |
49 | Ragged-red muscle fibers (HP:0003200) | 2.83637313 |
50 | Lipoatrophy (HP:0100578) | 2.80063240 |
51 | Muscle fiber splitting (HP:0003555) | 2.78447563 |
52 | * CNS demyelination (HP:0007305) | 2.77987539 |
53 | Abnormality of alanine metabolism (HP:0010916) | 2.77222676 |
54 | Hyperalaninemia (HP:0003348) | 2.77222676 |
55 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.77222676 |
56 | Abnormality of the calf musculature (HP:0001430) | 2.72209694 |
57 | Exertional dyspnea (HP:0002875) | 2.71442431 |
58 | Pheochromocytoma (HP:0002666) | 2.70271772 |
59 | Lethargy (HP:0001254) | 2.70224588 |
60 | Supraventricular tachycardia (HP:0004755) | 2.69609276 |
61 | Myotonia (HP:0002486) | 2.67639879 |
62 | Neuroendocrine neoplasm (HP:0100634) | 2.67486491 |
63 | Primary atrial arrhythmia (HP:0001692) | 2.62361999 |
64 | Supraventricular arrhythmia (HP:0005115) | 2.59254185 |
65 | Dilated cardiomyopathy (HP:0001644) | 2.54872843 |
66 | Muscle stiffness (HP:0003552) | 2.50484222 |
67 | Paralysis (HP:0003470) | 2.47180770 |
68 | Respiratory difficulties (HP:0002880) | 2.46524634 |
69 | Progressive external ophthalmoplegia (HP:0000590) | 2.43772713 |
70 | * Emotional lability (HP:0000712) | 2.40566299 |
71 | Generalized aminoaciduria (HP:0002909) | 2.37423196 |
72 | Syncope (HP:0001279) | 2.36462913 |
73 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.36190750 |
74 | Premature graying of hair (HP:0002216) | 2.34045585 |
75 | Abnormality of urine glucose concentration (HP:0011016) | 2.29470901 |
76 | Glycosuria (HP:0003076) | 2.29470901 |
77 | Hemiplegia (HP:0002301) | 2.24460551 |
78 | Vomiting (HP:0002013) | 2.21894838 |
79 | Abnormal trabecular bone morphology (HP:0100671) | 2.21888611 |
80 | Methylmalonic aciduria (HP:0012120) | 2.21842182 |
81 | EMG: myopathic abnormalities (HP:0003458) | 2.21062752 |
82 | Ketoacidosis (HP:0001993) | 2.14579259 |
83 | Abnormality of renal resorption (HP:0011038) | 2.13391340 |
84 | Prolonged QT interval (HP:0001657) | 2.12444761 |
85 | Microvesicular hepatic steatosis (HP:0001414) | 2.12193468 |
86 | Asymmetric septal hypertrophy (HP:0001670) | 2.08381128 |
87 | Testicular atrophy (HP:0000029) | 2.08360232 |
88 | Reduced antithrombin III activity (HP:0001976) | 2.05853933 |
89 | Severe muscular hypotonia (HP:0006829) | 2.05661721 |
90 | Short femoral neck (HP:0100864) | 2.03463984 |
91 | Neoplasm of head and neck (HP:0012288) | 2.02980271 |
92 | Esophageal neoplasm (HP:0100751) | 2.02980271 |
93 | Tongue fasciculations (HP:0001308) | 2.02974821 |
94 | * Gliosis (HP:0002171) | 1.97110098 |
95 | Type 1 muscle fiber predominance (HP:0003803) | 1.97106088 |
96 | Hyporeflexia of lower limbs (HP:0002600) | 1.96176519 |
97 | Cholecystitis (HP:0001082) | 1.94422256 |
98 | Abnormal gallbladder physiology (HP:0012438) | 1.94422256 |
99 | Conjunctival hamartoma (HP:0100780) | 1.93427583 |
100 | Cerebral hypomyelination (HP:0006808) | 1.93198316 |
101 | Type II lissencephaly (HP:0007260) | 1.92366170 |
102 | Squamous cell carcinoma (HP:0002860) | 1.91994038 |
103 | X-linked dominant inheritance (HP:0001423) | 1.90254327 |
104 | Type I transferrin isoform profile (HP:0003642) | 1.90163671 |
105 | Abnormal number of erythroid precursors (HP:0012131) | 1.90053801 |
106 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.90019660 |
107 | Hyperglycinuria (HP:0003108) | 1.89956323 |
108 | Ketosis (HP:0001946) | 1.89629876 |
109 | Methylmalonic acidemia (HP:0002912) | 1.89193805 |
110 | Left ventricular hypertrophy (HP:0001712) | 1.88483341 |
111 | Unsteady gait (HP:0002317) | 1.86325536 |
112 | Hyperammonemia (HP:0001987) | 1.85796864 |
113 | Progressive muscle weakness (HP:0003323) | 1.85686009 |
114 | Hypoglycemic coma (HP:0001325) | 1.85640713 |
115 | Ventricular arrhythmia (HP:0004308) | 1.85303534 |
116 | Distal arthrogryposis (HP:0005684) | 1.85070960 |
117 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.85061450 |
118 | Cerebral palsy (HP:0100021) | 1.84858831 |
119 | Abnormal EKG (HP:0003115) | 1.83697636 |
120 | Metabolic acidosis (HP:0001942) | 1.83450643 |
121 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.82414289 |
122 | Progressive microcephaly (HP:0000253) | 1.81188896 |
123 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.80728881 |
124 | Subaortic stenosis (HP:0001682) | 1.80508087 |
125 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.80508087 |
126 | Abnormal protein glycosylation (HP:0012346) | 1.79528629 |
127 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.79528629 |
128 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.79528629 |
129 | Abnormal glycosylation (HP:0012345) | 1.79051753 |
130 | Areflexia of lower limbs (HP:0002522) | 1.78002800 |
131 | Muscle fibrillation (HP:0010546) | 1.74932924 |
132 | Hypoplasia of the pons (HP:0012110) | 1.73883169 |
133 | Pendular nystagmus (HP:0012043) | 1.73201378 |
134 | Hypoplasia of the uterus (HP:0000013) | 1.69790360 |
135 | Abnormality of glycolipid metabolism (HP:0010969) | 1.67721200 |
136 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.67721200 |
137 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.67721200 |
138 | Microretrognathia (HP:0000308) | 1.65324141 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 3.74889496 |
2 | MYLK | 3.53198971 |
3 | OBSCN | 3.41917512 |
4 | VRK2 | 3.37973313 |
5 | MUSK | 2.99549891 |
6 | STK16 | 2.90848471 |
7 | BLK | 2.78339244 |
8 | ARAF | 2.76482470 |
9 | NME1 | 2.64854337 |
10 | NME2 | 2.64747030 |
11 | PHKG2 | 2.56956764 |
12 | PHKG1 | 2.56956764 |
13 | TLK1 | 2.40846931 |
14 | LMTK2 | 2.40308349 |
15 | TTN | 2.24561613 |
16 | ZAK | 2.23995194 |
17 | PDK3 | 2.13678285 |
18 | PDK4 | 2.13678285 |
19 | PIM2 | 2.13027643 |
20 | BRD4 | 2.09121466 |
21 | MAP3K12 | 2.07763827 |
22 | VRK1 | 1.96902706 |
23 | GRK7 | 1.93293633 |
24 | CDK12 | 1.79173621 |
25 | PINK1 | 1.68976008 |
26 | PDK2 | 1.66368037 |
27 | BUB1 | 1.62506010 |
28 | NEK1 | 1.61712142 |
29 | CDK19 | 1.61687603 |
30 | IRAK3 | 1.50501413 |
31 | MAP3K11 | 1.49906351 |
32 | MAP2K7 | 1.48245216 |
33 | BRAF | 1.41145913 |
34 | GRK1 | 1.35957298 |
35 | PRKD3 | 1.35422775 |
36 | EIF2AK3 | 1.32937773 |
37 | CASK | 1.32417863 |
38 | DAPK2 | 1.27962781 |
39 | DAPK3 | 1.26792876 |
40 | CSNK1G3 | 1.24334744 |
41 | WNK4 | 1.18933904 |
42 | ERN1 | 1.18818958 |
43 | TIE1 | 1.16484621 |
44 | PIK3CA | 1.14519764 |
45 | CSNK1A1L | 1.13647251 |
46 | TESK2 | 1.13454701 |
47 | CAMK2D | 1.13405051 |
48 | STK39 | 1.08768513 |
49 | OXSR1 | 1.07967559 |
50 | GRK5 | 1.07372019 |
51 | KDR | 0.97488448 |
52 | MAPK13 | 0.96975801 |
53 | STK4 | 0.96258492 |
54 | CCNB1 | 0.95540933 |
55 | CAMK2G | 0.93464699 |
56 | MAP2K3 | 0.92236752 |
57 | EIF2AK1 | 0.92235294 |
58 | MAP4K2 | 0.91937825 |
59 | MAPK11 | 0.90065588 |
60 | TESK1 | 0.89606744 |
61 | TSSK6 | 0.88207818 |
62 | RPS6KL1 | 0.87012380 |
63 | RPS6KC1 | 0.87012380 |
64 | CAMK4 | 0.86058577 |
65 | TEC | 0.83920828 |
66 | SMG1 | 0.83608410 |
67 | PKN1 | 0.82666602 |
68 | ILK | 0.81510932 |
69 | CSNK1G2 | 0.81457552 |
70 | MAPK12 | 0.79636383 |
71 | CSNK1G1 | 0.79104498 |
72 | MAPKAPK5 | 0.78809412 |
73 | RPS6KA6 | 0.78068527 |
74 | LIMK1 | 0.76636903 |
75 | IKBKB | 0.75908284 |
76 | TAF1 | 0.74558090 |
77 | TBK1 | 0.70994482 |
78 | BMPR1B | 0.70353169 |
79 | STK24 | 0.68961483 |
80 | MAP4K1 | 0.65724302 |
81 | WEE1 | 0.64290530 |
82 | CAMK2A | 0.63824314 |
83 | PRKAA1 | 0.63380462 |
84 | CDK8 | 0.63202584 |
85 | CAMKK2 | 0.61957342 |
86 | TNK2 | 0.61713264 |
87 | CAMK2B | 0.59943382 |
88 | PAK6 | 0.56934659 |
89 | ADRBK2 | 0.55120658 |
90 | ROCK2 | 0.54755808 |
91 | ABL2 | 0.53402101 |
92 | AKT2 | 0.50931196 |
93 | MARK3 | 0.49820892 |
94 | PRKCI | 0.48034850 |
95 | PRKACA | 0.46233402 |
96 | CDK9 | 0.44945115 |
97 | ROCK1 | 0.44724069 |
98 | MAP2K2 | 0.44060342 |
99 | FLT3 | 0.43633679 |
100 | PBK | 0.43331954 |
101 | PRKD2 | 0.42600929 |
102 | PRKCE | 0.42432835 |
103 | SYK | 0.41973836 |
104 | TNIK | 0.41261945 |
105 | NUAK1 | 0.40847776 |
106 | PIM1 | 0.40451816 |
107 | TAOK3 | 0.39969414 |
108 | MAP2K6 | 0.39654479 |
109 | CAMK1 | 0.38406821 |
110 | MAP3K3 | 0.37121244 |
111 | MAP2K4 | 0.37073746 |
112 | UHMK1 | 0.36067294 |
113 | RPS6KA5 | 0.35887360 |
114 | MAPK15 | 0.35844657 |
115 | INSRR | 0.35659179 |
116 | SIK2 | 0.35581218 |
117 | PRKD1 | 0.35501493 |
118 | MAP3K5 | 0.35143315 |
119 | AURKA | 0.33983693 |
120 | TRIB3 | 0.33020922 |
121 | MAP3K4 | 0.32889548 |
122 | PRKCQ | 0.32849847 |
123 | HIPK2 | 0.32756517 |
124 | PRKG2 | 0.32436899 |
125 | GRK6 | 0.32285111 |
126 | DYRK2 | 0.30111779 |
127 | PRKACB | 0.29751311 |
128 | MAP3K6 | 0.29296663 |
129 | PDPK1 | 0.28772372 |
130 | TAOK2 | 0.28225579 |
131 | RPS6KA2 | 0.26509420 |
132 | MAPK4 | 0.26400020 |
133 | PIK3CG | 0.24587669 |
134 | MKNK2 | 0.23182587 |
135 | KIT | 0.22693952 |
136 | ADRBK1 | 0.21117415 |
137 | CSNK2A1 | 0.20587920 |
138 | PAK1 | 0.19589617 |
139 | DAPK1 | 0.19391974 |
140 | MAPKAPK3 | 0.19120661 |
141 | PRKCD | 0.18308085 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 5.60870678 |
2 | Parkinsons disease_Homo sapiens_hsa05012 | 4.96851278 |
3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.28605893 |
4 | Alzheimers disease_Homo sapiens_hsa05010 | 3.59030911 |
5 | Huntingtons disease_Homo sapiens_hsa05016 | 3.40215694 |
6 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.23808302 |
7 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 3.19162854 |
8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.91169537 |
9 | Alcoholism_Homo sapiens_hsa05034 | 2.68717174 |
10 | Ribosome_Homo sapiens_hsa03010 | 2.57098788 |
11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.45704174 |
12 | Proteasome_Homo sapiens_hsa03050 | 2.43003271 |
13 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.05083296 |
14 | RNA polymerase_Homo sapiens_hsa03020 | 2.02160687 |
15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.01706151 |
16 | Carbon metabolism_Homo sapiens_hsa01200 | 1.98100321 |
17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.94691845 |
18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.84365739 |
19 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.79344478 |
20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.75367605 |
21 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.74719345 |
22 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.70474931 |
23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.70121118 |
24 | Sulfur relay system_Homo sapiens_hsa04122 | 1.52498968 |
25 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.51119982 |
26 | Protein export_Homo sapiens_hsa03060 | 1.38081214 |
27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.28319763 |
28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.26572410 |
29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.25752912 |
30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.21828831 |
31 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.20724134 |
32 | Peroxisome_Homo sapiens_hsa04146 | 1.19927612 |
33 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.19458908 |
34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.18041455 |
35 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13573356 |
36 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.09649490 |
37 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.08698204 |
38 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.07534751 |
39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06118150 |
40 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.04956515 |
41 | * Metabolic pathways_Homo sapiens_hsa01100 | 1.03058113 |
42 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.99195000 |
43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96238508 |
44 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.94180268 |
45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.93779227 |
46 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.88488260 |
47 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.88406882 |
48 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.87035593 |
49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.84920762 |
50 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80159752 |
51 | Purine metabolism_Homo sapiens_hsa00230 | 0.77710286 |
52 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.72748256 |
53 | DNA replication_Homo sapiens_hsa03030 | 0.71507301 |
54 | Nicotine addiction_Homo sapiens_hsa05033 | 0.71190655 |
55 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.70447414 |
56 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70418042 |
57 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.69337038 |
58 | Asthma_Homo sapiens_hsa05310 | 0.69044046 |
59 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.68039424 |
60 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.65914407 |
61 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64938698 |
62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.63259936 |
63 | Insulin secretion_Homo sapiens_hsa04911 | 0.63034837 |
64 | Mismatch repair_Homo sapiens_hsa03430 | 0.61760808 |
65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58685336 |
66 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58612286 |
67 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.57875116 |
68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.57793895 |
69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51777506 |
70 | Basal transcription factors_Homo sapiens_hsa03022 | 0.50236057 |
71 | Homologous recombination_Homo sapiens_hsa03440 | 0.48190064 |
72 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.47138829 |
73 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.45176120 |
74 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.44387981 |
75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44194321 |
76 | Base excision repair_Homo sapiens_hsa03410 | 0.44134307 |
77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43612290 |
78 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.42828790 |
79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41148014 |
80 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.40360471 |
81 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.39554007 |
82 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.39523967 |
83 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.39490118 |
84 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39055876 |
85 | Morphine addiction_Homo sapiens_hsa05032 | 0.38711910 |
86 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.36481163 |
87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.35322992 |
88 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.34877537 |
89 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.34458756 |
90 | Salivary secretion_Homo sapiens_hsa04970 | 0.34458281 |
91 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.34061316 |
92 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.33901319 |
93 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.33556912 |
94 | GABAergic synapse_Homo sapiens_hsa04727 | 0.33527167 |
95 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.32027570 |
96 | Histidine metabolism_Homo sapiens_hsa00340 | 0.31363300 |
97 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.31152959 |
98 | Lysosome_Homo sapiens_hsa04142 | 0.30482964 |
99 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.29430386 |
100 | Circadian entrainment_Homo sapiens_hsa04713 | 0.28880086 |
101 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.28472108 |
102 | Phototransduction_Homo sapiens_hsa04744 | 0.28090354 |
103 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.27861502 |
104 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.27343027 |
105 | RNA degradation_Homo sapiens_hsa03018 | 0.27313511 |
106 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.26774383 |
107 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.26619485 |
108 | Renin secretion_Homo sapiens_hsa04924 | 0.26232453 |
109 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.25370708 |
110 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.25196171 |
111 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.24103405 |
112 | Spliceosome_Homo sapiens_hsa03040 | 0.23839466 |
113 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.23291630 |
114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22865201 |
115 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.22178002 |
116 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.21601197 |
117 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.20613443 |
118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.20293215 |
119 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.19690471 |
120 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.19586412 |
121 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.16054913 |
122 | Other glycan degradation_Homo sapiens_hsa00511 | 0.15357580 |
123 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.14314461 |
124 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.13848412 |
125 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.12923911 |
126 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.12140938 |
127 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.08050123 |
128 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.07534436 |
129 | Retinol metabolism_Homo sapiens_hsa00830 | 0.06875308 |
130 | Taste transduction_Homo sapiens_hsa04742 | 0.06796483 |
131 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.05974032 |
132 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05008793 |